Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01204957 · ClinicalTrials.gov registry record · Phase 1
Brown Seaweed as a Breast Cancer Preventive
A Phase 1 study, sponsored by University of South Carolina.
- Completed
- Registry status
- Phase 1
- Development phase
- 33
- Enrollment target
NCT01204957 is a Phase 1 study that has completed, run by University of South Carolina. The registered enrollment target is 33 participants.
The verdict
NCT01204957, a Phase 1 study, has completed, sponsored by University of South Carolina.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 33 participants
- Enrollment target
Study Summary
Japanese postmenopausal women in Japan have about one ninth the rate of American postmenopausal women. Rates of breast cancer double even after just ten years among Japanese women who migrate to the US. Diet is thought to be an important factor, and the investigators were interested in whether dietary seaweed, with and without soy supplements, could influence known biomarkers of breast cancer risk in American women.
Interventions
- DIETARY_SUPPLEMENT Seaweed and Soy Protein
- DIETARY_SUPPLEMENT Placebo and Soy Protein
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 1998-10 |
| Est. Completion | 1999-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01204957
The ClinicalTrials.gov registry entry for NCT01204957 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of South Carolina, which has 157 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Seaweed and Soy Protein is the first listed.
NCT01204957 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01204957 about?
NCT01204957 is a clinical study titled "Brown Seaweed as a Breast Cancer Preventive". Japanese postmenopausal women in Japan have about one ninth the rate of American postmenopausal women. Rates of breast cancer double even after just ten years among Japanese women who migrate to the US. Diet is thought to be an important factor, and the investigators were interested in whether dieta...
What is the current status of trial NCT01204957?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 33 participants. The study started on 1998-10. Estimated completion is 1999-03.
What interventions are being tested in trial NCT01204957?
The interventions under investigation include: Seaweed and Soy Protein (DIETARY_SUPPLEMENT), Placebo and Soy Protein (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01204957?
This trial is sponsored by University of South Carolina, which has 157 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.